{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T12:15:51Z","timestamp":1771676151324,"version":"3.50.1"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2013,12,5]],"date-time":"2013-12-05T00:00:00Z","timestamp":1386201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,1,1]]},"abstract":"<jats:title>Learning Objectives<\/jats:title>\n               <jats:p>Describe the association between risk factors for renal cell carcinoma and the outcome of sunitinib treatment for metastatic disease. Explain the impact of active smoking on the outcome of sunitinib-treated metastatic renal cell carcinoma. Discuss obesity, hypertension, and diabetes in relation to the outcome of sunitinib-treated metastatic renal cell carcinoma.<\/jats:p>","DOI":"10.1634\/theoncologist.2012-0335","type":"journal-article","created":{"date-parts":[[2013,12,6]],"date-time":"2013-12-06T02:35:00Z","timestamp":1386297300000},"page":"51-60","source":"Crossref","is-referenced-by-count":54,"title":["Active Smoking May Negatively Affect Response Rate, Progression-Free Survival, and Overall Survival of Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib"],"prefix":"10.1093","volume":"19","author":[{"given":"Daniel","family":"Keizman","sequence":"first","affiliation":[{"name":"Genitourinary Oncology Service, Institute of Oncology, Meir Medical Center and the Sackler School of Medicine, Tel Aviv University, Kfar-Saba, Israel;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maya","family":"Gottfried","sequence":"additional","affiliation":[{"name":"Genitourinary Oncology Service, Institute of Oncology, Meir Medical Center and the Sackler School of Medicine, Tel Aviv University, Kfar-Saba, Israel;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maya","family":"Ish-Shalom","sequence":"additional","affiliation":[{"name":"Genitourinary Oncology Service, Institute of Oncology, Meir Medical Center and the Sackler School of Medicine, Tel Aviv University, Kfar-Saba, Israel;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie","family":"Maimon","sequence":"additional","affiliation":[{"name":"Genitourinary Oncology Service, Institute of Oncology, Meir Medical Center and the Sackler School of Medicine, Tel Aviv University, Kfar-Saba, Israel;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avivit","family":"Peer","sequence":"additional","affiliation":[{"name":"Department of Oncology, Rambam Medical Center, Haifa, Israel;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avivit","family":"Neumann","sequence":"additional","affiliation":[{"name":"Department of Oncology, Rambam Medical Center, Haifa, Israel;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Hammers","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario A.","family":"Eisenberger","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Sinibaldi","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Pili","sequence":"additional","affiliation":[{"name":"Roswell Park Cancer Institute, Buffalo, New York, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"Hayat","sequence":"additional","affiliation":[{"name":"Department of Oncology, Wolfson Medical Center, Holon, Israel;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Svetlana","family":"Kovel","sequence":"additional","affiliation":[{"name":"Department of Oncology, Asaf Harofe Medical Center, Zerifin, Israel;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avishay","family":"Sella","sequence":"additional","affiliation":[{"name":"Department of Oncology, Asaf Harofe Medical Center, Zerifin, Israel;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"Boursi","sequence":"additional","affiliation":[{"name":"Department of Oncology, Sheba Medical Center, Tel Hashomer, Israel;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rony","family":"Weitzen","sequence":"additional","affiliation":[{"name":"Department of Oncology, Sheba Medical Center, Tel Hashomer, Israel;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilmosh","family":"Mermershtain","sequence":"additional","affiliation":[{"name":"Department of Oncology, Soroka University Medical Center, Beer-sheva, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keren","family":"Rouvinov","sequence":"additional","affiliation":[{"name":"Department of Oncology, Soroka University Medical Center, Beer-sheva, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raanan","family":"Berger","sequence":"additional","affiliation":[{"name":"Department of Oncology, Sheba Medical Center, Tel Hashomer, Israel;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Carducci","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2013,12,5]]},"reference":[{"key":"2021122308520784300_B1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","article-title":"Global cancer statistics, 2002","volume":"55","author":"Parkin","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"2021122308520784300_B2","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s00345-004-0466-0","article-title":"Novel approaches in the therapy of metastatic renal cell carcinoma","volume":"23","author":"Lam","year":"2005","journal-title":"World J Urol"},{"key":"2021122308520784300_B3","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1056\/NEJM199609193351207","article-title":"Renal-cell carcinoma","volume":"335","author":"Motzer","year":"1996","journal-title":"N Engl J Med"},{"key":"2021122308520784300_B4","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0094-0143(03)00056-9","article-title":"Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease","volume":"30","author":"Janzen","year":"2003","journal-title":"Urol Clin North Am"},{"key":"2021122308520784300_B5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJMoa065044","article-title":"Sunitinib versus interferon alfa in metastatic renal-cell carcinoma","volume":"356","author":"Motzer","year":"2007","journal-title":"N Engl J Med"},{"key":"2021122308520784300_B6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/ijc.20618","article-title":"Renal cell carcinoma in relation to cigarette smoking: Meta-analysis of 24 studies","volume":"114","author":"Hunt","year":"2005","journal-title":"Int J Cancer"},{"key":"2021122308520784300_B7","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJM200011023431804","article-title":"Obesity, hypertension, and the risk of kidney cancer in men","volume":"343","author":"Chow","year":"2000","journal-title":"N Engl J Med"},{"key":"2021122308520784300_B8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s001250051122","article-title":"The role of diabetes mellitus in the aetiology of renal cell cancer","volume":"42","author":"Lindblad","year":"1999","journal-title":"Diabetologia"},{"key":"2021122308520784300_B9","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1002\/cncr.26453","article-title":"Smoking negatively impacts renal cell carcinoma overall and cancer-specific survival","volume":"118","author":"Kroeger","year":"2012","journal-title":"Cancer"},{"key":"2021122308520784300_B10","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1001\/jama.2011.879","article-title":"Smoking and prostate cancer survival and recurrence","volume":"305","author":"Kenfield","year":"2011","journal-title":"JAMA"},{"key":"2021122308520784300_B11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10147-011-0334-z","article-title":"Difference in survival and prognostic factors between smokers and never-smokers with advanced non-small-cell lung cancer","volume":"18","author":"Tanaka","year":"2013","journal-title":"Int J Clin Oncol"},{"key":"2021122308520784300_B12","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3816\/CLC.2006.n.022","article-title":"Smoking history and epidermal growth factor receptor expression as predictors of survival benefit from erlotinib for patients with non-small-cell lung cancer in the National Cancer Institute of Canada Clinical Trials Group study BR.21","volume":"7","author":"Clark","year":"2006","journal-title":"Clin Lung Cancer"},{"key":"2021122308520784300_B13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.lungcan.2009.04.006","article-title":"Prognostic factors for limited-stage small cell lung cancer: A study of 284 patients","volume":"67","author":"Chen","year":"2010","journal-title":"Lung Cancer"},{"key":"2021122308520784300_B14","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1016\/j.juro.2013.01.024","article-title":"Impact of smoking status on bladder tumor recurrence after radical nephroureterectomy for upper tract urothelial carcinoma","volume":"189","author":"Hagiwara","year":"2013","journal-title":"J Urol"},{"key":"2021122308520784300_B15","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.eururo.2012.06.029","article-title":"Impact of smoking on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy","volume":"63","author":"Rink","year":"2013","journal-title":"Eur Urol"},{"key":"2021122308520784300_B16","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S1470-2045(09)70240-2","article-title":"Resistance to targeted therapy in renal-cell carcinoma","volume":"10","author":"Rini","year":"2009","journal-title":"Lancet Oncol"},{"key":"2021122308520784300_B17","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ygyno.2010.12.329","article-title":"The impact of diabetes on survival in women with ovarian cancer","volume":"121","author":"Bakhru","year":"2011","journal-title":"Gynecol Oncol"},{"key":"2021122308520784300_B18","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.urology.2010.03.059","article-title":"Clinical outcomes after radical prostatectomy in diabetic patients treated with metformin","volume":"76","author":"Patel","year":"2010","journal-title":"Urology"},{"key":"2021122308520784300_B19","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1245\/s10434-010-0996-1","article-title":"Impact of diabetes mellitus on the prognosis of patients with oral squamous cell carcinoma: A retrospective cohort study","volume":"17","author":"Wu","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"2021122308520784300_B20","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.breast.2011.07.015","article-title":"Relationship between body mass index and preoperative treatment response to aromatase inhibitor exemestane in postmenopausal patients with primary breast cancer","volume":"21","author":"Takada","year":"2012","journal-title":"Breast"},{"key":"2021122308520784300_B21","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1016\/j.ejca.2011.06.038","article-title":"Influence of body mass index on outcome in advanced colorectal cancer patients receiving chemotherapy with or without targeted therapy","volume":"47","author":"Simkens","year":"2011","journal-title":"Eur J Cancer"},{"key":"2021122308520784300_B22","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"2021122308520784300_B23","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.ejca.2012.02.050","article-title":"Bisphosphonates combined with sunitinib may improve the response rate, progression free survival and overall survival of patients with bone metastases from renal cell carcinoma","volume":"48","author":"Keizman","year":"2012","journal-title":"Eur J Cancer"},{"key":"2021122308520784300_B24","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/annonc\/mdq342","article-title":"Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinoma","volume":"22","author":"Patil","year":"2011","journal-title":"Ann Oncol"},{"key":"2021122308520784300_B25","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1002\/cncr.23776","article-title":"Prognostic nomogram for sunitinib in patients with metastatic renal cell carcinoma","volume":"113","author":"Motzer","year":"2008","journal-title":"Cancer"},{"key":"2021122308520784300_B26","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1200\/JCO.2007.13.3223","article-title":"Efficacy of sunitinib and sorafenib in metastatic papillary and chromophobe renal cell carcinoma","volume":"26","author":"Choueiri","year":"2008","journal-title":"J Clin Oncol"},{"key":"2021122308520784300_B27","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/jnci\/djr128","article-title":"Hypertension as a biomarker of efficacy in patients with metastatic renal cell carcinoma treated with sunitinib","volume":"103","author":"Rini","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"2021122308520784300_B28","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.1200\/JCO.2008.21.4809","article-title":"Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: Results from a large, multicenter study","volume":"27","author":"Heng","year":"2009","journal-title":"J Clin Oncol"},{"key":"2021122308520784300_B29","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/j.ejca.2011.04.019","article-title":"Angiotensin system inhibitors and outcome of sunitinib treatment in patients with metastatic renal cell carcinoma: A retrospective examination","volume":"47","author":"Keizman","year":"2011","journal-title":"Eur J Cancer"},{"key":"2021122308520784300_B30","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ejca.2011.09.001","article-title":"The association of pre-treatment neutrophil to lymphocyte ratio with response rate, progression free survival and overall survival of patients treated with sunitinib for metastatic renal cell carcinoma","volume":"48","author":"Keizman","year":"2012","journal-title":"Eur J Cancer"},{"key":"2021122308520784300_B31","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1056\/NEJM199301213280302","article-title":"Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer","volume":"328","author":"Browman","year":"1993","journal-title":"N Engl J Med"},{"key":"2021122308520784300_B32","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S1470-2045(09)70162-7","article-title":"Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: An expanded-access trial","volume":"10","author":"Gore","year":"2009","journal-title":"Lancet Oncol"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pericles-gcp.literatumonline.com\/doi\/pdf\/10.1634\/theoncologist.2012-0335","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/pericles-gcp.literatumonline.com\/doi\/full-xml\/10.1634\/theoncologist.2012-0335","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/19\/1\/51\/41861625\/oncolo_19_1_51.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/19\/1\/51\/41861625\/oncolo_19_1_51.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T01:29:16Z","timestamp":1640309356000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/19\/1\/51\/6400002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,5]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,12,5]]},"published-print":{"date-parts":[[2014,1,1]]}},"URL":"https:\/\/doi.org\/10.1634\/theoncologist.2012-0335","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2014,1,1]]},"published":{"date-parts":[[2013,12,5]]}}}